https://www.selleckchem.com/pr....oducts/pci-34051.htm
In 81 patients no adverse events or SADE occurred. Statistically significant changes in ventricular PCT (0.034 ± 0.15 V) immediately after, ventricular LI immediately after (-18.7 ± 44.2 Ω) and 1 month post phase B (-19.8 ± 44.9 Ω), and atrial sensing attenuation immediately after (-0.27 ± 0.92 mV) and 1 month post phase B (-0.22 ± 0.92 mV) were noted. However, these changes were not clinically relevant in degree. These results demonstrate the safety and performance of the ProMRI PPM in patients undergoing 3 serial MRIs over various a
Curtir
Comentario
Compartilhar
